OFI Invest Asset Management Makes New $34,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

OFI Invest Asset Management acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, Holdings Channel reports. The fund acquired 455 shares of the company’s stock, valued at approximately $34,000.

A number of other hedge funds have also recently bought and sold shares of the company. United Community Bank raised its stake in shares of GE HealthCare Technologies by 2,891.9% during the 4th quarter. United Community Bank now owns 1,107 shares of the company’s stock worth $87,000 after purchasing an additional 1,070 shares during the period. Amundi raised its stake in shares of GE HealthCare Technologies by 45.9% during the 4th quarter. Amundi now owns 1,726,902 shares of the company’s stock worth $148,963,000 after purchasing an additional 542,944 shares during the period. Larson Financial Group LLC raised its stake in shares of GE HealthCare Technologies by 21.2% during the 4th quarter. Larson Financial Group LLC now owns 3,807 shares of the company’s stock worth $298,000 after purchasing an additional 665 shares during the period. Machina Capital S.A.S. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $765,000. Finally, Andra AP fonden raised its stake in shares of GE HealthCare Technologies by 431.6% during the 4th quarter. Andra AP fonden now owns 50,500 shares of the company’s stock worth $3,948,000 after purchasing an additional 41,000 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 0.3 %

GEHC stock opened at $85.59 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $39.14 billion, a PE ratio of 19.77, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The stock has a 50-day simple moving average of $87.06 and a two-hundred day simple moving average of $86.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $85.00 to $100.00 in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.